Type A Cranberry Extract Proanthocyanidins: The Scientific Key to Urinary Tract Health

Type A Cranberry Extract Proanthocyanidins: The Scientific Key to Urinary Tract Health

Urinary tract infections (UTIs) are a major global health concern that predominantly affect women. They significantly impair quality of life and impose a heavy burden on healthcare systems. Statistics show that approximately 50% of women will experience at least one UTI in their lifetime, and such infections tend to recur frequently. As researchers seek alternative solutions to antibiotics and supplementary preventive measures, cranberry extract has attracted widespread attention for its potential in supporting urinary tract health.

Core Function of Proanthocyanidins (PACs)
The urinary health benefits of cranberry extract are primarily attributed to a group of polyphenolic compounds known as cranberry extract proanthocyanidins (PACs). However, not all PACs are functionally identical. In nature, PACs exist in two main structural forms: Type A and Type B.
Type B PACs: Widely present in numerous plants such as apples, grapes, and cocoa.
Type A PACs: Highly concentrated in cranberries.
It is this unique Type A structure that endows cranberry with distinctive anti-adhesive properties, which are not found in common foods containing only Type B PACs.

Mechanism of Action: Anti-Adhesion Effect
Pathogenic Escherichia coli is the primary pathogen responsible for urinary tract infections. These bacteria attach to urethral epithelial cells on the inner bladder wall via their surface P-fimbriae. Once attached, they colonize, multiply, and trigger inflammatory infections.
Type A PACs in cranberry extract provide protective effects through a three-stage mechanism:
Block adhesion: Type A PACs bind to the fimbriae on the surface of E. coli.
Inhibit colonization: This binding prevents bacteria from adhering to the inner lining of the urinary tract.
Natural elimination: Unattached bacteria are excreted from the body with urine, preventing infections at the source.

36 mg Daily Intake Standard & Content Detection Specification
The actual efficacy of cranberry products hinges fundamentally on the content and quality of Type A PACs.
Scientific studies have confirmed that a daily intake of 36 mg of cranberry extract Type A PACs is the standard effective dosage to achieve anti-adhesive effects.
Inconsistent detection methodologies have long been an industry challenge. Currently, the BL-DMAC assay is the globally recognized standard for quantifying cranberry extract Type A PAC content. It accurately measures active concentrations, ensuring consumers receive sufficient bioactive ingredients.

Conclusion
Not all cranberry products deliver equivalent urinary health benefits. The critical difference lies in the presence and concentration of Type A PACs.
Andy Biotech is dedicated to supplying high-quality cranberry extracts that effectively support public urinary tract health.
With growing global concerns over antibiotic resistance, this science-backed natural protective ingredient is gaining increasing value in the nutrition and healthcare industry.

Andy Biotech has produced and export Plant extract powder since 2012 and got zero complants from all the clients.Quality is the most important thing that we are focous on.For more information,pls contact sales@andybiotech.com